Methods Mentioned
BETA
Flow cytometry
Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
BMC Public Health
Guillermo Salinas-EscuderoJuan Garduño-Espinosa
BMC Bioinformatics
Ichcha ManipurMario R Guarracino
Correction to: Relevance of biomarkers across different neurodegenerative diseases
(opens in new tab)Alzheimer's Research & Therapy
Alexander J EhrenbergRoss W Paterson
Radiation Oncology
P FreisledererV Batista
World Journal of Surgical Oncology
Antoni Lluecaon behalf MUAPOS Working Group